Creating new imaging agents to study Alzheimer's disease
Development of Novel γ-Secretase PET Agents for the Exploration of AD Pathology
This study is looking at new ways to use special imaging tools to see a protein in the brains of people with Alzheimer's disease, which could help us understand how the disease works and find better treatments in the future.
Quick facts
| Grant type | R03 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11044149 on NIH RePORTER |
What this research studies
This research focuses on developing novel PET imaging agents that can visualize and quantify the presence of γ-secretase in the brains of individuals with Alzheimer's disease. By using these agents, researchers aim to better understand the role of γ-secretase in the progression of Alzheimer's and its associated pathology. The approach involves non-invasive imaging techniques that could correlate molecular changes with cognitive deficits in patients. This could ultimately aid in the discovery of new therapeutic targets for Alzheimer's treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's disease or those at risk of developing it.
Not a fit: Patients with other forms of dementia or cognitive impairment unrelated to Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved diagnostic tools and targeted therapies for Alzheimer's disease.
How similar studies have performed: Previous research has shown promise in using imaging agents to study Alzheimer's pathology, indicating that this approach could be effective.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Xu, Yulong — Massachusetts General Hospital
- Study coordinator: Xu, Yulong
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.